# Safety and Effectiveness of tPA in Intra-abdominal Abscesses

> **NCT00417768** · PHASE2,PHASE3 · TERMINATED · sponsor: **University Health Network, Toronto** · enrollment: 35 (actual)

## Conditions studied

- Abscess

## Interventions

- **DRUG:** Tissue Plasminogen Activator
- **OTHER:** Normal Saline

## Key facts

- **NCT ID:** NCT00417768
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-07
- **Primary completion:** 2012-07
- **Final completion:** 2013-11
- **Target enrollment:** 35 (ACTUAL)
- **Why stopped:** Change in patient population no longer fit study criteria.
- **Last updated:** 2014-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00417768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00417768, "Safety and Effectiveness of tPA in Intra-abdominal Abscesses". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00417768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*